These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2876796)

  • 1. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
    Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension.
    Black HR; Chrysant SG; Curry CL; Frishman WH; Grimm RH; Lasseter KC; Okun R; Pool JL; Raizada V; Vlachakis ND
    J Clin Pharmacol; 1992 Apr; 32(4):351-9. PubMed ID: 1349028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
    Saunders E
    Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic alpha 1-blockade with terazosin does not modify insulin sensitivity in nonobese normotensive subjects.
    Ferrari P; Rosman J; Neuner N; Shaw S; Riesen W; Weidmann P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):106-10. PubMed ID: 1719277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
    Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
    Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL
    Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terazosin: a new alpha adrenoceptor blocking drug.
    Achari R; Laddu A
    J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
    Goto Y
    Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and endocrinological effects of a new selective alpha 1-blocking agent, terazosin, in patients with essential hypertension. Results of long-term treatment.
    Tomoda F; Takata M; Yoshida K; Yasumoto K; Mikawa M; Sasayama S
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):834-9. PubMed ID: 2574044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pressure and metabolic effects of terazosin in essential hypertension].
    Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
    Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.